Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder
{{output}}
Study objectives: Lemborexant (LEM) is a dual orexin receptor antagonist approved for treating adults with insomnia. We analyzed the efficacy (subjective sleep outcomes) and safety of LEM over 12 months in the subgroup of Asian s... ...
